Rivadeneyra-Domínguez Eduardo, Zamora-Bello Isaac, Juárez-Zaragoza Erik Raúl, Rosales-Sánchez Óscar, Guillén-Ruiz Gabriel, Rodríguez-Landa Juan Francisco
Laboratorio de Farmacotoxicología, Facultad de Química Farmacéutica Biológica, Universidad Veracruzana, Xalapa, 91000, México.
Laboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa, 91190, México.
BMC Complement Med Ther. 2025 May 31;25(1):193. doi: 10.1186/s12906-025-04934-7.
Long-term cassava (Manihot esculenta Crantz) intake has been associated with the development of neurological diseases characterized by motor impairment in humans and experimental animals. Thus, there is a need to identify the therapeutic effects of molecules to ameliorate said alterations, such as resveratrol, which was explored in the present study. Therefore, we evaluate whether the behavioral alterations associated with the chronic intake of cassava juice could be reversed with resveratrol.
Adult male rats were randomly assigned to four independent groups (n = 8): vehicle (purified water), cassava (28.56 mg/kg), resveratrol (10.70 mg/kg), and a combination of treatments (cassava plus resveratrol). Vehicle and cassava juices were administered from days 1 to 28, followed by vehicle or resveratrol from days 29 to 56. The effects of the treatments were evaluated on days 28 and 56 in the open field test, rotarod, and swimming test, compared with the baseline.
Cassava juice increased crossing, rearing, and grooming in the open field, produced a short latency to fall from the rotarod, and increased the spin behavior and the total time of immobility in the swimming test. These effects were reversed by resveratrol.
Resveratrol could be considered in the development of therapeutic strategies for neurological disorders associated with cassava consumption.
Not applicable.
长期食用木薯(Manihot esculenta Crantz)已被证明与人类和实验动物中以运动障碍为特征的神经疾病的发展有关。因此,有必要确定能够改善上述改变的分子的治疗效果,比如本研究中所探究的白藜芦醇。因此,我们评估了与长期饮用木薯汁相关的行为改变是否可以通过白藜芦醇来逆转。
成年雄性大鼠被随机分为四个独立组(n = 8):溶剂对照组(纯净水)、木薯组(28.56毫克/千克)、白藜芦醇组(10.70毫克/千克)以及联合治疗组(木薯加白藜芦醇)。从第1天到第28天给予溶剂对照和木薯汁,然后从第29天到第56天给予溶剂对照或白藜芦醇。与基线相比,在第28天和第56天通过旷场试验、转棒试验和游泳试验评估治疗效果。
木薯汁增加了旷场试验中的穿越、直立和理毛行为,缩短了转棒试验中的跌落潜伏期,并增加了游泳试验中的旋转行为和静止总时间。这些作用被白藜芦醇逆转。
在制定与食用木薯相关的神经疾病的治疗策略时可考虑使用白藜芦醇。
不适用。